Research Topics
Species | E L MattesonSummaryAffiliation: Mayo Clinic Country: USA Publications
Research Grants
| Collaborators
|
Detail Information
Publications
Malignancy as a comorbidity in rheumatic diseasesCarl Turesson
Mayo Clinic, 200 1st Street SW, Rochester, MN 55905, USA
Rheumatology (Oxford) 52:5-14. 2013..Effective screening and monitoring strategies are important in reducing the risk of cancer in these patients...
History of vasculitis: the life and work of Adolf KussmaulEric L Matteson
Division of Rheumatology, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA
Cleve Clin J Med 79:S54-6. 2012..A much-loved teacher and respected physician and researcher, Kussmaul's desire to understand disease, his careful clinical observations, and his innovative thinking in medical technology mark him as a pioneer in modern rheumatology...
A profile of immune response to herpesvirus is associated with radiographic joint damage in rheumatoid arthritisJohn M Davis
Division of Rheumatology, Department of Medicine, College of Medicine, Mayo Clinic 200 First Street SW, Rochester, MN 55905, USA
Arthritis Res Ther 14:R24. 2012..This study was undertaken to identify profiles of immune response that correlate with radiographic joint damage as a first step toward the discovery of new pathogenic mechanisms of joint destruction in RA...
Patient-reported outcomes in polymyalgia rheumaticaEric L Matteson
Department of Internal Medicine, Division of Rheumatology, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA
J Rheumatol 39:795-803. 2012..To prospectively evaluate the disease course and the performance of clinical, patient-reported outcome (PRO) and musculoskeletal ultrasound measures in patients with polymyalgia rheumatica (PMR)...
Orthopedic surgery among patients with rheumatoid arthritis 1980-2007: a population-based study focused on surgery rates, sex, and mortalityCourtney A Shourt
Department of Medicine, Division of Rheumatology, Mayo Clinic, Rochester, MN 55905, USA
J Rheumatol 39:481-5. 2012..To describe current trends in arthritis-related joint surgery among a population-based cohort of patients with rheumatoid arthritis (RA) and to examine the influence of joint surgery on mortality...
2012 provisional classification criteria for polymyalgia rheumatica: a European League Against Rheumatism/American College of Rheumatology collaborative initiativeBhaskar Dasgupta
Department of Rheumatology, Southend University Hospital, Westcliff on Sea, Essex, UK
Ann Rheum Dis 71:484-92. 2012..These criteria are not meant for diagnostic purposes...
Histoplasmosis infection in patients with rheumatoid arthritis, 1998-2009Timothy C Olson
Department of Internal Medicine, Mayo Clinic College of Medicine, Rochester, Minnesota 55905, USA
BMC Infect Dis 11:145. 2011..Patients with rheumatic diseases including rheumatoid arthritis (RA) are at increased risk for infections related to both the disease and its treatments. These include uncommonly reported infections due to histoplasmosis...
Response to commentary by Dixon and Silman on the systematic review and meta-analysis by Bongartz et alEric L Matteson
Arthritis Res Ther 8:404. 2006
Increased risk of peripheral arterial disease in polymyalgia rheumatica: a population-based cohort studyKenneth J Warrington
Department of Medicine, Division of Rheumatology, Mayo Clinic, Rochester, MN 55905, USA
Arthritis Res Ther 11:R50. 2009..The present study was conducted to determine whether patients with polymyalgia rheumatica (PMR) are at an increased risk of peripheral arterial disease (PAD)...
Cardiovascular risk factors and acute-phase response in idiopathic ascending aortitis: a case control studyVaidehi R Chowdhary
Division of Rheumatology, Department of Medicine, Mayo Clinic College of Medicine, 200 1st Street SW, Rochester, MN 55905, USA
Arthritis Res Ther 11:R29. 2009..Idiopathic aortitis is a rare condition characterized by giant cell or lymphoplasmacytic inflammation of the aorta. The purpose of this study was to describe risk factors for the development of idiopathic aortitis...
The impact of HLA-DRB1 genes on extra-articular disease manifestations in rheumatoid arthritisCarl Turesson
Department of Rheumatology, Malmo University Hospital, Södra Förstadsgatan 101, 205 02 Malmo, Sweden
Arthritis Res Ther 7:R1386-93. 2005..This confirms that SE genes contribute to RA disease severity and ExRA. Other genetic and environmental factors may have a more specific impact on individual ExRA manifestations...
Effects of cyclophosphamide on pulmonary function in patients with scleroderma and interstitial lung disease: a systematic review and meta-analysis of randomized controlled trials and observational prospective cohort studiesCarlotta Nannini
Division of Rheumatology, Mayo Clinic College of Medicine, 200 First Street SW, Rochester, MN 55905, USA
Arthritis Res Ther 10:R124. 2008..The purpose of the present study was to systematically review the effect of cyclophosphamide treatment on pulmonary function in patients with systemic sclerosis and interstitial lung disease...
How aggressive should initial therapy for rheumatoid arthritis be? Factors associated with response to 'non-aggressive' DMARD treatment and perspective from a 2-yr open label trialE L Matteson
Division of Rheumatology, Mayo Clinic and Mayo Graduate School of Medicine, Rochester, MN 55905, USA
Rheumatology (Oxford) 43:619-25. 2004..To determine what baseline factors might be associated with response to an initial mild treatment regimen in patients with early rheumatoid arthritis (RA)...
Are classification criteria for vasculitis useful in clinical practice? Observations and lessons from ColombiaPaúl Alejandro Méndez Patarroyo
Department of Internal Medicine, Rheumatology Unit, Universidad Nacional de Colombia, Bogota, Columbia
J Autoimmune Dis 6:1. 2009....
Etanercept therapy for immune-mediated cochleovestibular disorders: a multi-center, open-label, pilot studyEric L Matteson
Mayo Clinic College of Medicine, Rochester, Minnesota 55905, USA
Arthritis Rheum 53:337-42. 2005..The objective of the current study was to preliminarily evaluate the efficacy of etanercept therapy for IMCVD...
Historical perspective of vasculitis: polyarteritis nodosa and microscopic polyangiitisEric L Matteson
Division of Rheumatology, Mayo Clinic and Foundation, 200 1st Street SE, Rochester, MN 55905, USA
Curr Rheumatol Rep 4:67-74. 2002..Historically, most forms of vasculitis described subsequently have been characterized and classified on the basis of features similar to or distinct from polyarteritis...
Think clearly, be sincere, act calmly: Adolf Kussmaul (February 22, 1822-May 28, 1902) and his relevance to medicine in the 21st centuryEric L Matteson
Division of Rheumatology and Internal Medicine, Mayo Clinic, Rochester, MN 55905, USA
Curr Opin Rheumatol 15:29-34. 2003..Kussmaul's life and career, dedicated foremost to reducing human suffering and advancing medicine as a scientific discipline with a strong humanistic foundation, make him a role model for physicians of today...
Citrullination in extra-articular manifestations of rheumatoid arthritisT Bongartz
Division of Rheumatology, Mayo Clinic College of Medicine, 200 1St St SW Rochester, MN 55905, USA
Rheumatology (Oxford) 46:70-5. 2007..We therefore investigated the presence of citrullination in two extra-articular manifestations of RA, interstitial pneumonia (IP) and rheumatoid nodules...
Fatal sepsis in a patient with rheumatoid arthritis treated with etanerceptM Baghai
Department of Surgery, Mayo Clinic, Rochester, Minn 55905, USA
Mayo Clin Proc 76:653-6. 2001....
Open trial of methotrexate as treatment for autoimmune hearing lossE L Matteson
Division of Rheumatology, Mayo Clinic and Foundation, Rochester, Minnesota 55905, USA
Arthritis Rheum 45:146-50. 2001..CONCLUSION: Long-term low-dose MTX therapy may be a useful therapy for at least some patients who have hearing loss with a presumptively autoimmune-mediated component that is refractory to traditional therapies...
Incidence of noncardiac vascular disease in rheumatoid arthritis and relationship to extraarticular disease manifestationsKimberly P Liang
Mayo Clinic and Mayo Graduate School of Medicine, Rochester, Minnesota, USA
Arthritis Rheum 54:642-8. 2006..Similar to cardiac disease, the excess risk of noncardiac vascular disease in RA is likely to be related, in part, to the systemic inflammation associated with the extraarticular manifestations of RA...
Which measure of inflammation to use? A comparison of erythrocyte sedimentation rate and C-reactive protein measurements from randomized clinical trials of golimumab in rheumatoid arthritisCynthia S Crowson
Division of Rheumatology, Mayo Clinic, Rochester, MN, USA
J Rheumatol 36:1606-10. 2009..To assess clinical utility of measurements of C-reactive protein (CRP) versus Westergren erythrocyte sedimentation rate (ESR) in evaluating patients with rheumatoid arthritis (RA)...
Mycophenolate mofetil is effective in reducing disease flares in systemic lupus erythematosus patients: a retrospective studyC Nannini
Division of Rheumatology, Mayo Clinic College of Medicine, Rochester, Minnesota 55905, USA
Lupus 18:394-9. 2009..MMF treatment significantly reduced the total number of lupus flares and prednisone requirements. Even with the reduction in mean daily prednisone dose, both the SLEDAI and physican global assessment also improved during MMF therapy...
Etanercept therapy in rheumatoid arthritis and the risk of malignancies: a systematic review and individual patient data meta-analysis of randomised controlled trialsT Bongartz
Division of Rheumatology, Mayo Clinic College of Medicine, Rochester, MN, USA
Ann Rheum Dis 68:1177-83. 2009..To assess the risk of malignancy with etanercept, a fusion protein that inhibits TNF action, a meta-analysis was performed using individual patient data from randomised controlled trials (RCT) in patients with rheumatoid arthritis (RA)...
The utility of positron emission tomography in the evaluation of autoimmune hearing lossMehrdad Mazlumzadeh
Division of Rheumatology, Mayo Clinic, Rochester, Minnesota, USA
Otol Neurotol 24:201-4. 2003..CONCLUSIONS: Positron emission tomography, especially when combined with HSP-70 determination, may be a useful technique for assessing disease in patients with autoimmune inner ear disease...
Modulation of CD28 expression with anti-tumor necrosis factor alpha therapy in rheumatoid arthritisEwa Bryl
Mayo Clinic College of Medicine, Rochester, Minnesota, USA
Arthritis Rheum 52:2996-3003. 2005..CONCLUSION: Overproduction of TNFalpha in RA induces a global down-regulation of CD28 in CD4+ T cells and may cause reduced sensitivity to costimulatory signals in T cell responses...
Costimulating aberrant T cell responses by B7-H1 autoantibodies in rheumatoid arthritisHaidong Dong
Department of Immunology, Mayo Medical School and Graduate School, Mayo Clinic, Rochester, Minnesota 55905, USA
J Clin Invest 111:363-70. 2003....
Severe extra-articular disease manifestations are associated with an increased risk of first ever cardiovascular events in patients with rheumatoid arthritisC Turesson
Division of Rheumatology, Mayo Clinic College of Medicine, Rochester, Minnesota, USA
Ann Rheum Dis 66:70-5. 2007..Rheumatoid arthritis is associated with increased cardiovascular mortality and morbidity...
Rheumatoid factor and antibodies to cyclic citrullinated peptides are associated with severe extra-articular manifestations in rheumatoid arthritisC Turesson
Department of Rheumatology, Malmo University Hospital, Södra Förstadsgatan 101, S 205 02 Malmo, Sweden
Ann Rheum Dis 66:59-64. 2007..To study antibodies to cyclic citrullinated peptides (anti-CCP) and rheumatoid factor in patients with active, severe extra-articular rheumatoid arthritis (ExRA) compared with controls without ExRA...
Extra-articular disease manifestations in rheumatoid arthritis: incidence trends and risk factors over 46 yearsC Turesson
Department of Rheumatology, Malmo University Hospital, Lund University, Sweden
Ann Rheum Dis 62:722-7. 2003..To investigate the trends in incidence of extra-articular rheumatoid arthritis (ExRA) in a well defined community based cohort of patients with rheumatoid arthritis (RA), and to examine possible predictors of ExRA occurrence...
Is tacrolimus effective for treating antisynthetase-associated interstitial lung disease?Tim Bongartz
Division of Rheumatology, Mayo Clinic, Rochester, MN 55905, USA
Nat Clin Pract Rheumatol 1:80-1. 2005
Incidence and mortality of interstitial lung disease in rheumatoid arthritis: a population-based studyTim Bongartz
Rheumatology Department, Mayo Clinic College of Medicine, Rochester, Minnesota 55905, USA
Arthritis Rheum 62:1583-91. 2010..Interstitial lung disease (ILD) has been recognized as an important comorbidity in rheumatoid arthritis (RA). We undertook the current study to assess incidence, predictors, and mortality of RA-associated ILD...
Association of HLA-C3 and smoking with vasculitis in patients with rheumatoid arthritisCarl Turesson
Department of Rheumatology, Malmo University Hospital, Malmo, Sweden
Arthritis Rheum 54:2776-83. 2006..To compare HLA-C genotypes and smoking habits in patients with vasculitis or other severe extraarticular manifestations of rheumatoid arthritis (ExRA) with those in RA patients without extraarticular disease...
Systemic lupus erythematosus features in rheumatoid arthritis and their effect on overall mortalityMurat Icen
Department of Health Sciences Research, Mayo Foundation, 200 First St SW, Rochester, MN 55905, USA
J Rheumatol 36:50-7. 2009..However, their frequency and clinical significance are uncertain. We examined the frequency of SLE features in RA and their effect on overall mortality...
Cardiovascular risk factors, fitness and physical activity in rheumatic diseasesCarl Turesson
Department of Rheumatology, Malmo University Hospital, Malmo, Sweden
Curr Opin Rheumatol 19:190-6. 2007..In this review, we highlight recent findings on risk factors for cardiovascular disease in patients with rheumatic diseases, and explore the role of physical activity for the prevention of cardiovascular disease...
Primer: Demystifying risk--understanding and communicating medical risksCynthia S Crowson
Department of Health Sciences Research, all at the Mayo Clinic, Rochester, MN 55905, USA
Nat Clin Pract Rheumatol 3:181-7; quiz 1 p following 187. 2007..In the face of uncertainty, making a provisional decision with a plan to review it later can be a good strategy. Verifying the patient's comprehension can help ensure that the decisions reached are informed and acceptable...
Cancer preceding giant cell arteritis: a case-control studyTanaz A Kermani
Mayo Clinic, Rochester, Minnesota 55905, USA
Arthritis Rheum 62:1763-9. 2010..To study the association between previous cancer and giant cell arteritis (GCA)...
Malignancy risk in patients with giant cell arteritis: a population-based cohort studyTanaz A Kermani
Mayo Clinic, Rochester, Minnesota 55905, USA
Arthritis Care Res (Hoboken) 62:149-54. 2010..To determine the incidence of cancer in a population-based cohort of patients with giant cell arteritis (GCA) compared with age- and sex-matched referent subjects...
Analysis of complex biomarkers for human immune-mediated disorders based on cytokine responsiveness of peripheral blood cellsJohn M Davis
Division of Rheumatology, Department of Medicine, College of Medicine, Mayo Clinic, Rochester, MN 55905, USA
J Immunol 184:7297-304. 2010..Thus, our approach lays the foundation for the development of immunologic "signatures" that could be useful in predicting disease course and monitoring the outcomes of therapy among patients with immune-mediated diseases...
Anti-cyclic citrullinated peptide, rheumatoid factor, and ocular symptoms typical of rheumatoid arthritisSujit Itty
Mayo Medical School, Mayo Clinic, Rochester, Minnesota, USA
Trans Am Ophthalmol Soc 106:75-81; discussion 81-3. 2008..To correlate the presence of anti-cyclic citrullinated peptide (anti-CCP) antibodies and rheumatoid factor (RF) with ocular symptoms typical of rheumatoid arthritis (RA)...
Lack of association of high body mass index with risk for developing polymyalgia rheumaticaDeana D Hoganson
Division of Rheumatology, Mayo Clinic, Rochester, MN 55905, USA
Int J Rheum Dis 13:e1-5. 2010..Objectives: To determine the association between BMI and polymyalgia rheumatica (PMR) as well as the influence of BMI on glucocorticoid treatment duration and development of giant-cell arteritis (GCA) in patients with PMR...
Vasculitis in rheumatoid arthritisCarl Turesson
Department of Rheumatology, Malmo University Hospital, Malmo, Sweden
Curr Opin Rheumatol 21:35-40. 2009..To examine the occurrence and pathophysiology of vasculitis in rheumatoid arthritis (RA), describe the epidemiology and clinical features, and provide a therapeutic perspective...
Incidence and risk factors of prosthetic joint infection after total hip or knee replacement in patients with rheumatoid arthritisTim Bongartz
Mayo Clinic College of Medicine, Division of Rheumatology, Rochester, Minnesota 55905, USA
Arthritis Rheum 59:1713-20. 2008..We conducted a study to evaluate potential risk factors of prosthetic joint infection and to clarify if RA is an independent predictor of this complication...
Cardiovascular co-morbidity in rheumatic diseasesCarl Turesson
Department of Rheumatology, Malmo University Hospital, Malmo, Sweden
Vasc Health Risk Manag 4:605-14. 2008..In this review, the research agenda for understanding and preventing CVD co-morbidity in patients with rheumatic disorders is discussed...
Biologic response modifiers for ophthalmologistsJames A Garrity
Department of Ophthalmology, Mayo Clinic, Rochester, Minnesota 55905, USA
Ophthal Plast Reconstr Surg 24:345-7. 2008
Cogan's syndrome: an audiovestibular, ocular, and systemic autoimmune diseaseMehrdad Mazlumzadeh
Mayo Clinic College of Medicine, Rochester, MN 55901, USA
Rheum Dis Clin North Am 33:855-74, vii-viii. 2007..A poor outcome, especially complete hearing loss, can sometimes be prevented through a timely recognition and initiation of glucocorticoid therapy at the onset of the disease...
Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in randomized controlled trialsTim Bongartz
Division of Rheumatology and Department of Internal Medicine, Mayo Clinic College of Medicine, Rochester, Minn 55905, USA
JAMA 295:2275-85. 2006..Tumor necrosis factor (TNF) plays an important role in host defense and tumor growth control. Therefore, anti-TNF antibody therapies may increase the risk of serious infections and malignancies...
Treatment of recalcitrant idiopathic orbital inflammation (chronic orbital myositis) with infliximabJames A Garrity
Department of Ophthalmology, Mayo Clinic, Rochester, Minnesota 55905, USA
Am J Ophthalmol 138:925-30. 2004..To report results of treatment with a monoclonal antibody (infliximab) directed against tumor necrosis factor alpha in seven patients with chronic and difficult-to-control idiopathic orbital inflammation (orbital myositis)...
Prognostic markers of radiographic progression in early rheumatoid arthritisJorg J Goronzy
Mayo Clinic, Rochester, Minnesota 55905, USA
Arthritis Rheum 50:43-54. 2004..To identify prognostic markers that are predictive of progressive erosive disease in patients with early rheumatoid arthritis (RA)...
Increased CD4+ T cell infiltrates in rheumatoid arthritis-associated interstitial pneumonitis compared with idiopathic interstitial pneumonitisCarl Turesson
Mayo Clinic College of Medicine, 200 First Street SW, Rochester, MN 55905, USA
Arthritis Rheum 52:73-9. 2005..To study lymphocyte markers in rheumatoid arthritis (RA)-associated interstitial pneumonitis (IP) compared with idiopathic IP...
Concomitant giant cell aortitis, thoracic aortic aneurysm, and aortic arch syndrome: occurrence in a patient and significanceDirk M Nuenninghoff
Mayo Clinic and Mayo Graduate School of Medicine, 200 First Street SW, Rochester, MN 55905, USA
Arthritis Rheum 49:858-61. 2003
Infectious complications of tumor necrosis factor-alpha antagonistsMohanad Bakleh
Division of Infectious Diseases and Rheumatology, Department of Internal Medicine, Mayo Clinic College of Medicine, Rochester, Minnesota 55905, USA
Int J Dermatol 44:443-8. 2005
Lyme myositisAaron R Holmgren
Mayo Clinic, Rochester, Minnesota 55905, USA
Arthritis Rheum 54:2697-700. 2006..The current case is reviewed in the context of findings from previous case descriptions...
Genetics of rheumatoid arthritisCarl Turesson
Division of Rheumatology, Mayo Clinic College of Medicine, Rochester, Minn 55905, USA
Mayo Clin Proc 81:94-101. 2006....
Survival in rheumatoid arthritis: a population-based analysis of trends over 40 yearsSherine E Gabriel
Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota 55905, USA
Arthritis Rheum 48:54-8. 2003..To evaluate trends in and risk factors for mortality among patients with rheumatoid arthritis (RA) over a 40-year period...
Morphologic and quantitative assessment of CD20+ B cell infiltrates in rheumatoid arthritis-associated nonspecific interstitial pneumonia and usual interstitial pneumoniaSarah R Atkins
Mayo Clinic College of Medicine, Rochester, Minnesota 55905, USA
Arthritis Rheum 54:635-41. 2006....
Autoimmune inner ear disease: diagnostic and therapeutic approaches in a multidisciplinary settingEric L Matteson
Department of Internal Medicine, Division of Rheumatology Mayo Clinic and Mayo Graduate School of Medicine Rochester, Minnesota 55905, USA
J Am Acad Audiol 14:225-30. 2003..One of our conclusions is that many of these patients respond favorably to the treatment Methotrexate...
Symptomatic lower extremity vasculitis in giant cell arteritis: a case seriesTanaz A Kermani
Division of Rheumatology, Department of Medicine, Mayo Clinic, 200 First Street SW, Rochester, MN 55901, USA
J Rheumatol 36:2277-83. 2009..To describe the clinical features and outcomes of 19 patients with giant cell arteritis (GCA) and symptomatic lower extremity (LE) vasculitis...
Cogan syndrome: a retrospective review of 60 patients throughout a half centuryMichael B Gluth
Department of Otorhinolaryngology, Mayo Clinic College of Medicine, Rochester, MN 55905, USA
Mayo Clin Proc 81:483-8. 2006....
No decrease over time in the incidence of vasculitis or other extraarticular manifestations in rheumatoid arthritis: results from a community-based studyCarl Turesson
Mayo Clinic College of Medicine, Rochester, Minnesota, USA
Arthritis Rheum 50:3729-31. 2004
Management of extra-articular disease manifestations in rheumatoid arthritisCarl Turesson
Division of Rheumatology, Mayo Clinic College of Medicine, 200 First Street SW, Rochester, MN 55905, USA
Curr Opin Rheumatol 16:206-11. 2004..To discuss the rationale for various treatment strategies in rheumatoid arthritis with extra-articular manifestations, and to review advances in understanding the impact of extra-articular rheumatoid arthritis and its management...
Renal involvement in primary Sjögren's syndrome: a clinicopathologic studySaugar Maripuri
Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota 55905, USA
Clin J Am Soc Nephrol 4:1423-31. 2009..Renal pathology and clinical outcomes in patients with primary Sjögren's syndrome (pSS) who underwent kidney biopsy (KB) because of renal impairment are reported...
Genetics of rheumatoid arthritis: Is there a pattern predicting extraarticular manifestations?Carl Turesson
Mayo Clinic College of Medicine, Rochester, Minnesota, USA
Arthritis Rheum 51:853-63. 2004
Interstitial lung disease in primary Sjögren syndromeJoseph G Parambil
Division of Pulmonary and Critical Care Medicine, Mayo Clinic, Rochester, MN 55905, USA
Chest 130:1489-95. 2006..Those with UIP tended to have progression of lung disease. Death from acute exacerbation of interstitial pneumonia may occur in patients with pSS-associated ILD...
Testicular involvement in rheumatoid vasculitisD F Mayer
Division of Rheumatology, Mayo Clinic College of Medicine, Rochester, Minnesota 55905, USA
Clin Exp Rheumatol 22:S62-4. 2004..This unusual presentation of rheumatoid vasculitis was successfully treated with a combination of corticosteroids and cyclophosphamide...
Recurrence of Susac syndrome (retinocochleocerebral vasculopathy) after remission of 18 yearsG W Petty
Division of Cerebrovascular Diseases, Mayo Clinic, Rochester, Minn 55905, USA
Mayo Clin Proc 76:958-60. 2001..Clinicians should be aware of the possibility of late recurrence of Susac syndrome when evaluating patients with a distant history of the syndrome who present with complaints referable to the brain, retina, and cochlea...
Assessment of disease activity in rheumatoid arthritis using a novel folate targeted radiopharmaceutical FolatescanE L Matteson
Division of Rheumatology, Mayo Clinic College of Medicine, Rochester, Minnesota 55905, USA
Clin Exp Rheumatol 27:253-9. 2009..This study is a preliminary assessment of the safety and usage of a radiopharmaceutical, FolateScan (Technetium-99m EC20; 99mTc-EC20), for detecting disease activity in patients with rheumatoid arthritis...
Incidence and predictors of large-artery complication (aortic aneurysm, aortic dissection, and/or large-artery stenosis) in patients with giant cell arteritis: a population-based study over 50 yearsDirk M Nuenninghoff
Mayo Clinic, Rochester, Minnesota 55905, USA
Arthritis Rheum 48:3522-31. 2003..67-0.95, P < 0.05] per 10 mm/hour). CONCLUSION: Large-artery complication is common in GCA. Increased awareness of large-artery complication in GCA, particularly early-occurring aortic dissection, may decrease associated mortality...
A patient remembers the miracle drug cortisone 50 years laterEric L Matteson
Division of Rheumatology, Mayo Clinic Rochester, USA
Minn Med 85:12-5. 2002
Lung disease in rheumatoid arthritisCarlotta Nannini
Division of Rheumatology, Mayo Clinic College of Medicine, Rochester, Minnesota, USA
Curr Opin Rheumatol 20:340-6. 2008..To examine the role of lung disease in rheumatoid arthritis from a clinical, epidemiologic, pathophysiologic, and therapeutic perspective...
Morphological and quantitative assessment of mast cells in rheumatoid arthritis associated non-specific interstitial pneumonia and usual interstitial pneumoniaS R Atkins
Division of Rheumatology, Mayo Clinic College of Medicine, Rochester, MN 55905, USA
Ann Rheum Dis 65:677-80. 2006..The findings provide a rationale for studying functional aspects of mast cell involvement in the pathogenesis of RA associated lung disease...
Management guidelines and outcome measures in giant cell arteritis (GCA)K J Warrington
Division of Rheumatology, Mayo Clinic College of Medicine, Rochester, MN 55905, USA
Clin Exp Rheumatol 25:137-41. 2007..Disease relapses and steroid-related adverse effects, however, are common. Serious complications of the disease may include visual loss, stroke, and aortic involvement with aneurysm formation...
Treatment of giant cell arteritis using induction therapy with high-dose glucocorticoids: a double-blind, placebo-controlled, randomized prospective clinical trialMehrdad Mazlumzadeh
Mayo Clinic, Scottsdale, Arizona, USA
Arthritis Rheum 54:3310-8. 2006....
Mortality of large-artery complication (aortic aneurysm, aortic dissection, and/or large-artery stenosis) in patients with giant cell arteritis: a population-based study over 50 yearsDirk M Nuenninghoff
Mayo Clinic, Rochester, Minnesota 55905, USA
Arthritis Rheum 48:3532-7. 2003..Overall, mortality in the whole group of patients with GCA with large-artery complication was similar to that in patients with GCA without large-artery complication...
Large-vessel involvement in giant cell arteritisTim Bongartz
Division of Rheumatology, Mayo Clinic College of Medicine, Rochester, Minnesota 55905, USA
Curr Opin Rheumatol 18:10-7. 2006..We provide a suggested algorithm for the evaluation of patients with large-vessel disease in giant cell arteritis...
The future of damage assessment in vasculitisPhilip Seo
Division of Rheumatology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
J Rheumatol 34:1357-71. 2007..This initiative is part of a larger international effort to create a unified approach to disease assessment for the primary systemic vasculitides...
Lack of detection of human retrovirus-5 proviral DNA in synovial tissue and blood specimens from individuals with rheumatoid arthritis or osteoarthritisKerryl E Piper
Division of Infectious Diseases, Dept. of Medicine, Mayo Clinic College of Medicine, 200 First Street SW, Rochester, MN 55905, USA
Arthritis Rheum 55:123-5. 2006..Our findings are consistent with the recent finding that human retrovirus 5 is actually rabbit endogenous retrovirus H...
Initial contributions of Adamantiades and BehçetKenneth T Calamia
Mayo Clinic and Mayo Graduate School of Medicine, Rochester, Minnesota, USA
Adv Exp Med Biol 528:3-5. 2003
Small-vessel vasculitisAntonio Iglesias Gamarra
Division of Rheumatology, Mayo Clinic College of Medicine, Southwest, Rochester, MN 55905, USA
Curr Rheumatol Rep 9:304-11. 2007....
The role of disease-modifying antirheumatic drugs in the treatment of giant cell arteritisD M Nuenninghoff
Division of Rheumatology, Mayo Clinic, 200 First Street SW, Rochester, Minnesota 55905, USA
Clin Exp Rheumatol 21:S29-34. 2003..Thus far, no disease-modifying antirheumatic drug therapy or alternative to daily glucocorticosteroid therapy has been found to be unequivocally effective in the treatment of GCA...
The Rochester Epidemiology Project: exploiting the capabilities for population-based research in rheumatic diseasesHilal Maradit Kremers
Department of Health Sciences Research, Mayo Clinic College of Medicine, Rochester, MN 55905, USA
Rheumatology (Oxford) 50:6-15. 2011....
Incidence of extraarticular rheumatoid arthritis in Olmsted County, Minnesota, in 1995-2007 versus 1985-1994: a population-based studyElena Myasoedova
Mayo Foundation, 200 First Street SW, Rochester, MN 55905, USA
J Rheumatol 38:983-9. 2011..To assess incidence and mortality effects of extraarticular rheumatoid arthritis (ExRA) in patients with incident RA in 1995-2007 compared to 1985-1994, in Olmsted County, Minnesota, USA...
Hearing loss in rheumatoid arthritisChristine S Halligan
Division of Rheumatology, Mayo Clinic College of Medicine, Rochester, Minnesota 55905, USA
Laryngoscope 116:2044-9. 2006..Subjectively patients with RA were more likely to perceive themselves as having hearing disturbances, which may be related to overall disease related functional impairment...
Polymyalgia rheumaticaClement J Michet
Division of Rheumatology, Mayo Clinic, Rochester, MN 55905, USA
BMJ 336:765-9. 2008
Declining use of orthopedic surgery in patients with rheumatoid arthritis? Results of a long-term, population-based assessmentEleonora da Silva
Universidade Federale de Sao Paulo, Brazil
Arthritis Rheum 49:216-20. 2003..To describe the use of orthopedic surgery, including joint replacement surgery, in a well-defined, population-based cohort of patients with rheumatoid arthritis (RA) and to identify characteristics that predict such use...
Tumor necrosis factor antagonists and infections: the small print on the price tagTim Bongartz
Arthritis Rheum 53:631-5. 2005
Bullous skin lesions following infliximab infusion in a patient with rheumatoid arthritisPeter D Kent
Arthritis Rheum 46:2257-8; author reply 2259. 2002
Managing comorbidity risks in rheumatoid arthritisSonja A Dechant
Curr Opin Rheumatol 16:177-9. 2004
An open-label, phase I/II study of 5-fluorouracil plus leucovorin in the treatment of rheumatoid arthritisThomas W Bunch
J Rheumatol 29:1109-10. 2002
Need for circumspection in prescribing tumor necrosis factor inhibitors and other biologic response modifiersEric L Matteson
Arthritis Rheum 47:1-4. 2002
Occurrence of extraarticular disease manifestations is associated with excess mortality in a community based cohort of patients with rheumatoid arthritisCarl Turesson
Department of Rheumatology, , Sweden
J Rheumatol 29:62-7. 2002....
A population based assessment of the use of orthopedic surgery in patients with rheumatoid arthritisLoreto Massardo
Department of Clinical Immunology and Rheumatology, Catholic University of Chile, Santiago
J Rheumatol 29:52-6. 2002..Reconstructive surgeries were common, and women had significantly more surgeries than men. Survivorship among patients with RA undergoing surgeries was similar to that of the RA patient population at large...
CD56-expressing T cells that have features of senescence are expanded in rheumatoid arthritisJoshua J Michel
Children s Hospital of Pittsburgh, Pittsburgh, Pennsylvania 15213, USA
Arthritis Rheum 56:43-57. 2007..T cells deficient in CD28 expression have been implicated in the pathogenesis of rheumatoid arthritis (RA). Given that CD28-null T cells are functionally heterogeneous, we undertook this study to screen for novel receptors on these cells...
Golimumab in patients with active rheumatoid arthritis despite treatment with methotrexate: a randomized, double-blind, placebo-controlled, dose-ranging studyJonathan Kay
Rheumatology Unit, Massachusetts General Hospital, and Harvard Medical School, Boston, Massachusetts 02114, USA
Arthritis Rheum 58:964-75. 2008..To assess the efficacy, safety, and pharmacology of subcutaneous administration of golimumab in patients with active rheumatoid arthritis (RA) despite treatment with methotrexate (MTX)...
Early detection of rheumatoid arthritis made easier. Accurate early diagnosis may facilitate treatment decisionsEric L Matteson
Health News 9:12-3. 2003
Citrullinated proteins in rheumatoid arthritis: crucial...but not sufficient!Tineke Cantaert
University of Amsterdam, Amsterdam, The Netherlands
Arthritis Rheum 54:3381-9. 2006
Signs of systemic disease are strong determinants of mortality in rheumatoid arthritis: comment on the article by Navarro-Cano et alCarl Turesson
Arthritis Rheum 50:1695-6; author reply 1696-7. 2004
Lupus arthropathy: a case series of patients with rhupusAndres Fernandez
Department of Internal Medicine, Rheumatology Unit, Universidad Nacional de Colombia, Bogota, Colombia
Clin Rheumatol 25:164-7. 2006..8 years. All had positive antinuclear antibody and rheumatoid factor. Rhupus arthritis is not a combination of RA and SLE, but should be regarded as a variant of the arthropathy of lupus...
An historical review of systemic lupus erythematosus in Latin AmericaAntonio Iglesias Gamarra
Internal Medicine and Rheumatology, National University of Colombia, Bogota, Colombia
Med Sci Monit 10:RA171-85. 2004..The investigation of lupus continues to be pursued by a very dedicated group of Latin American researchers, who continue to enhance our understanding of the pathogenesis and treatment of this condition...
Lupus arthropathy: historical evolution from deforming arthritis to rhupusAndres Fernandez
Department of Internal Medicine, Rheumatology Unit, Universidad Nacional de Colombia, Bogota, Colombia
Clin Rheumatol 23:523-6. 2004..Instead, rhupus arthropathy should be regarded as a variant of the arthropathy of systemic lupus erythematosus...
Current status of outcome measures in vasculitis: focus on Wegener's granulomatosis and microscopic polyangiitis. Report from OMERACT 7Peter A Merkel
Boston University School of Medicine, Boston, MA 02118, USA
J Rheumatol 32:2488-95. 2005....
Research Grants
- Genetic Polymorphisms in Rheumatoid ArthritisEric Matteson; Fiscal Year: 2004..The mentorship program proposed in this grant is critical to this long-term goal. ..
